Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Eastern Academic Health Science Network

Health Innovation East | Supporting innovation to deliver positive health impact

Health Innovation East brings together academia, citizens, health services and industry to realise the value of innovations quicker. Share your experience today.

CRN
08530726
Founded
2013
Age
13

Overview

Legal name
EASTERN ACADEMIC HEALTH SCIENCE NETWORK
Region
East of England
Registered address
UNIT C, MAGOG COURT
SHELFORD BOTTOM
CAMBRIDGE
ENGLAND
CB22 3AD
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

8 events
24 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

26 May
2026

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzUyMzM4ODczMWFkaXF6a2N4

Published 26 May 2026 07:34

23 May
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUyMzM4ODYwOGFkaXF6a2N4

Published 23 May 2026 16:49

23 May
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUyMzM4ODU0OWFkaXF6a2N4

Published 23 May 2026 16:46

10 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

15 May
2013

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2023
Funded years
2023, 2024
Age at first award
10 years

Projects

2024 Collaborative R&D

Researching, designing and delivering VR-based mindfulness based cognitive therapy (VR MBCT) to Mind service users across the UK

1 Jun 2024 to 31 Oct 2025

Awarded
£80,944
Total cost £80,944

In partnership with Mind, the leading UK mental health charity and a leading academic institution, this is a pioneering project to deliver a recognised therapeutic method through an innovative, technologically advanced use of VR. This initiative, which is also supported by a regional health innovation group, aims to implement and evaluate a new delivery s...

2023 Collaborative R&D

Intelligent decision support for faster, more effective and lower-cost precision medicine for hypertension, cholesterol and diabetes with co-morbitities (ExpertCare).

1 Dec 2023 to 31 May 2025

Awarded
£156,000
Total cost £156,000

Cardiovascular disease (CVD) often manifests as more than one long-term condition. Multimorbidity, commonly described as the presence of multiple concurrent medical conditions, is more common with age and associated with high mortality, reduced functional status, and increased hospitalisation. It is estimated that by 2035, 17% of UK citizens above sixty-f...

Product types

Collaborative R&D